Business Description
Aequus Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA0076361033
Compare
Compare
Traded in other countries / regions
AQS.CanadaAEQ.GermanyAQSZF.USA IPO Date
2017-02-27Description
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | -4.53 | |||||
| Debt-to-Equity | -1.15 | |||||
| Debt-to-EBITDA | -2.92 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -56.08 | |||||
| Beneish M-Score | -9.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -58.5 | |||||
| 3-Year EBITDA Growth Rate | -88.2 | |||||
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year FCF Growth Rate | -23.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.17 | |||||
| 9-Day RSI | 48.9 | |||||
| 14-Day RSI | 50.44 | |||||
| 6-1 Month Momentum % | -96.67 | |||||
| 12-1 Month Momentum % | -94.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.09 | |||||
| Quick Ratio | 0.07 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 1089.34 | |||||
| Days Sales Outstanding | 133.11 | |||||
| Days Payable | 3137.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.8 | |||||
| Shareholder Yield % | -70.56 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.25 | |||||
| Operating Margin % | -1750.43 | |||||
| Net Margin % | -1864.96 | |||||
| FCF Margin % | -1215 | |||||
| ROA % | -195.4 | |||||
| ROIC % | -40.89 | |||||
| ROC (Joel Greenblatt) % | -314.12 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.5 | |||||
| EV-to-EBIT | -3.94 | |||||
| EV-to-EBITDA | -4.15 | |||||
| EV-to-Revenue | 68.95 | |||||
| EV-to-FCF | -6.14 | |||||
| Earnings Yield (Greenblatt) % | -25.39 | |||||
| FCF Yield % | -53.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aequus Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.08 | ||
| EPS (TTM) (€) | -0.01 | ||
| Beta | 0.54 | ||
| Volatility % | 163.86 | ||
| 14-Day RSI | 50.44 | ||
| 14-Day ATR (€) | 0.003932 | ||
| 20-Day SMA (€) | 0.00735 | ||
| 12-1 Month Momentum % | -94.12 | ||
| 52-Week Range (€) | 0.0005 - 0.053 | ||
| Shares Outstanding (Mil) | 132.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aequus Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aequus Pharmaceuticals Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aequus Pharmaceuticals Inc Frequently Asked Questions
What is Aequus Pharmaceuticals Inc(FRA:AEQ)'s stock price today?
The current price of FRA:AEQ is €0.01. The 52 week high of FRA:AEQ is €0.05 and 52 week low is €0.00.
When is next earnings date of Aequus Pharmaceuticals Inc(FRA:AEQ)?
The next earnings date of Aequus Pharmaceuticals Inc(FRA:AEQ) is .
Does Aequus Pharmaceuticals Inc(FRA:AEQ) pay dividends? If so, how much?
Aequus Pharmaceuticals Inc(FRA:AEQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers